Nasdaq Halts Charming Medical Limited
Rhea-AI Summary
Nasdaq (Nasdaq: NDAQ) announced a trading halt in Charming Medical Limited (Nasdaq: MCTA) while Nasdaq requests additional information from the company.
The Securities and Exchange Commission previously suspended trading in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The company\'s last reported sale price was $29.355. Trading will remain halted until Charming Medical Limited fully satisfies Nasdaq\'s information request. The SEC order is available at the SEC website linked in the announcement.
Positive
- SEC trading suspension ended on Nov 25, 2025
- Last reported share price was $29.355
Negative
- Nasdaq trading halt remains in effect pending additional information
- Prior SEC suspension covered Nov 12, 2025 to Nov 25, 2025
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was
More information about the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf.
Trading will remain halted until Charming Medical Limited has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
Nasdaq Contact:
Nasdaq MarketWatch
nasdaqmarketwatch@nasdaq.com
NDAQO